Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Irinotecan in Extensive Stage Small Cell Lung Cancer
NCT00316433Phase 2Terminated
- Sponsor
- Swedish Health Services
- Start
- Feb 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in small cell lung cancer (SCLC), sponsored by Swedish Health Services. Started Feb 2005; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00316433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316433.